USE OF GENERALIZED LINEAR MODEL TO FIND THE RELATIONSHIP BETWEEN DIAGNOSIS AND THE COST OF DIABETIC OUTPATIENTS

Author(s)

Xiao Wang, phD, GtaUniversity of Louisville, Louisville, KY, USA

OBJECTIVES The purpose of this paper is to evaluate the relationship between the patient diagnoses and the Claims for total charges for outpatients with diabetes. We examine treatments in relationship to costs. METHODS The dataset ‘Outpatient-base-claim'of size 2,030,078 used for this paper is taken from the Chronic Condition Data Warehouse, which contains claim information for the year 2004. In this study, we use Summary Statistics, One-Way Frequencies, the Generalized Linear model in SAS Enterprise Guide 4.1 and Kernel Density Estimation. We utilize Filter and Query, Append Table, Join Table as well as Random Sampling to preprocess the data in order to analyze it. Although this dataset contains ICD9 codes for both diagnosis and procedures, Deductible and Coinsurance and so on, we mainly concentrate on patient diagnosis information and total charges. One-way frequency counts gave us the top 20 reasons for total charges and we use these 20 diagnoses to define 0-1 indicator functions for regression. RESULTS The results of the Summary Statistics show that the total charges for diagnosis are reduced considerably for payment. Kernel Density Estimation shows that the distribution of the total charges follows a Gamma distribution and most of the charges are under 3500 dollars. The Generalized Linear Model shows that only 15 of the newly-generated factors are significant to the model, and these include Type II diabetes mellitus and chronic kidney disease. Renal failure is the most expensive condition to treat. CONCLUSIONS Diagnosis has an important effect on the total charges of diabetic patients, but only 15 out of 20 diseases such as unspecified essential hypertension and chronic kidney disease are statistically significant to the total charges. Chronic kidney disease has the most important effect on the total charges.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PDB25

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×